David Aronoff, MD
Pediatric Urology · Panama City, FLNPI 1821030925
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Procept Biorobotics Corporation at 32.7% of the total. Reporting peaked in 2022 at $2,646 and has fallen 89.6% since, to $274 in 2025. Among pediatric urology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $49.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$2K
- Boston Scientific$1K
- Teleflex LLC$675
- 180 Medical, Inc.$274
- Endo Pharmaceuticals Inc.$219
- Intuitive Surgical$210
- plus $1K from 29 others
What the payments were for
- Consulting fees$3506%
- Travel & lodging$2,29937%
- Food & beverage$3,50057%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 10 | $2,011 |
| Boston Scientific | 14 | $1,428 |
| Teleflex LLC | 8 | $675 |
| 180 Medical, Inc. | 11 | $274 |
| Endo Pharmaceuticals Inc. | 12 | $219 |
| Intuitive Surgical | 4 | $210 |
| Sumitomo Pharma America, Inc. | 7 | $139 |
| Pfizer | 1 | $103 |
| Myriad Genetic Laboratories, Inc. | 5 | $98 |
| Endo USA, Inc. | 4 | $92 |
| Amgen | 6 | $82 |
| Neotract Inc. | 2 | $74 |
| Dendreon Pharmaceuticals LLC | 4 | $72 |
| Progenics Pharmaceuticals, Inc. | 3 | $59 |
| Medtronic | 2 | $56 |
| Varian Medical Systems, Inc. | 3 | $55 |
| Merck | 3 | $51 |
| Olympus America Inc. | 2 | $44 |
| AstraZeneca | 1 | $43 |
| Johnson & Johnson | 3 | $42 |
| Urogen Pharma, Inc. | 2 | $36 |
| Sanofi | 2 | $35 |
| Blue Earth Diagnostics | 2 | $30 |
| Exelixis Inc. | 2 | $29 |
| Coloplast | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Edwards Lifesciences | 1 | $22 |
| Urovant Sciences Inc | 1 | $19 |
| Ambu Inc. | 1 | $17 |
| ABC Home Medical Supply, Inc. | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
| RGH Enterprises LLC | 1 | $13 |
| Myovant Sciences Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,149 in reported general payments places this provider in the 90th percentile of 39 pediatric urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 16 | $19,116 |
| MyrbetriqMirabegron | 28 | $15,709 |
| Estradiol | 52 | $3,217 |
| Desmopressin Acetate | 18 | $1,842 |
| Tamsulosin Hcl | 140 | $1,630 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 70 | $1,433 |
| Testosterone Cypionate | 33 | $1,349 |
| Finasteride | 134 | $1,318 |
| NitrofurantoinNitrofurantoin Macrocrystal | 18 | $888 |
| Oxybutynin Chloride ErOxybutynin Chloride | 44 | $367 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $146 |
| Oxybutynin Chloride | 21 | $118 |
| Ciprofloxacin Hcl | 30 | $104 |
| Cephalexin | 15 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $139 | $19,11616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 39 pediatric urology providers in Florida.
Other pediatric urology in Panama City
- Benjamin RheeOrlando$15K
- Rafael GosalbezMiami$8K
- Miguel CastellanMiami$8K
- Abdelrahman AbdelbarrTampa$5K
- Androniki KanaroglouBoyton Beach$4K
- Daniel NassauMiami$3K
- Manuel Cruz-DiazOrlando$3K
- Yuri ReinbergJacksonville$2K
- Yifan GriffinTampa$1K
- Mark RichOrlando$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.